Cellular carriers for drug delivery are attractive alternatives to synthetic nanoparticles owing
to their innate homing/targeting abilities. Here, we review molecular interactions involved in …

Over the last few decades galectin-3, a carbohydrate binding protein, with affinity for N-
acetyllactosamine residues, has been unique due to the regulatory roles it performs in …

In the past decade, mesenchymal stem cells (MSCs) tend to exhibit inherent tropism for
refractory inflammatory diseases and engineered MSCs have appeared on the market as …

The immunosuppressive capacity of human mesenchymal stromal cells (MSCs) renders
them promising candidates for treating diverse immune disorders. However, after hundreds …

Colorectal cancer is the third most incident and second most lethal type of cancer worldwide.
Lifestyle and dietary patterns are the key factors for higher disease development risk. The …

Bone-resorbing osteoclasts mobilize proteolytic enzymes belonging to the matrix
metalloproteinase (MMP) family to directly degrade type I collagen, the dominant …

Therapies based on transplantation of mesenchymal stromal cells (MSC) hold promise for
the management of inflammatory disorders. In chronic Chagas disease cardiomyopathy …

In acute myeloid leukemia (AML), high Galectin 3 (LGALS3) expression is associated with
poor prognosis. The role of LGALS3 derived from mesenchymal stromal cells (MSC) in the …

Hepatocellular carcinoma (HCC) is the most common fatal cancer worldwide, patients with
HCC have a high mortality rate and poor prognosis. PANoptosis is a novel discovery of …

Galectin-3 (GAL-3) is a beta-galactoside binding lectin produced by mesenchymal stem
cells (MSCs) and other cell sources under inflammatory conditions. Several studies have …